• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“天然”和“活化”备解素的解析与分析

Resolution and analysis of 'native' and 'activated' properdin.

作者信息

Farries T C, Finch J T, Lachmann P J, Harrison R A

出版信息

Biochem J. 1987 Apr 15;243(2):507-17. doi: 10.1042/bj2430507.

DOI:10.1042/bj2430507
PMID:3307764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1147884/
Abstract

A rapid and reproducible procedure for the resolution of 'native' and 'activated' forms of properdin (a component of the alternative activation pathway of complement), by gel filtration on the polyvinyl matrix Fractogel TSK HW-55(S), is reported. This fractionation permitted effective screening of samples for conditions that cause activation. Only 'native' properdin was detected in serum, even after activation of the alternative pathway by yeast cell walls. Transformation of 'native' into 'activated' properdin in vitro was produced by freeze-thawing of the protein, but not upon binding to and dissociation from the C3 convertase, C3bBb. Electron microscopy showed that only the 'native' population contained the discrete cyclic structures described previously by Smith, Pangburn, Vogel & Müller-Eberhard [(1984) J. Biol. Chem. 259, 4582-4588]. 'Activated' properdin, which was eluted from the gel-filtration column close to the breakthrough peak, was mainly composed of large amorphous aggregates. We therefore conclude that properdin 'activation' is not a physiological event that occurs in serum on complement activation, but is an artifact of isolation. Fractionation of properdin on Fractogel TSK HW-55(S) has, however, enabled detailed analysis of functional heterogeneity within the 'native' population.

摘要

本文报道了一种通过在聚乙烯基质Fractogel TSK HW-55(S)上进行凝胶过滤来分离备解素(补体替代激活途径的一个组分)“天然”形式和“活化”形式的快速且可重复的方法。这种分级分离允许对样品进行有效筛选,以寻找导致激活的条件。即使在酵母细胞壁激活替代途径后,血清中也仅检测到“天然”备解素。蛋白质的冻融可在体外将“天然”备解素转化为“活化”备解素,但与C3转化酶C3bBb结合和解离时则不会。电子显微镜显示,只有“天然”群体含有Smith、Pangburn、Vogel和Müller-Eberhard先前描述的离散环状结构[(1984年)《生物化学杂志》259, 4582 - 4588]。从凝胶过滤柱上靠近穿透峰处洗脱的“活化”备解素主要由大的无定形聚集体组成。因此,我们得出结论,备解素“激活”不是补体激活时血清中发生的生理事件,而是分离过程中的人为现象。然而,在Fractogel TSK HW-55(S)上对备解素进行分级分离,能够对“天然”群体内的功能异质性进行详细分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa2/1147884/776e12de87dd/biochemj00257-0204-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa2/1147884/24606debe986/biochemj00257-0197-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa2/1147884/776e12de87dd/biochemj00257-0204-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa2/1147884/24606debe986/biochemj00257-0197-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa2/1147884/776e12de87dd/biochemj00257-0204-a.jpg

相似文献

1
Resolution and analysis of 'native' and 'activated' properdin.“天然”和“活化”备解素的解析与分析
Biochem J. 1987 Apr 15;243(2):507-17. doi: 10.1042/bj2430507.
2
Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.备解素、补体第三成分(C3)及其生理激活产物之间的相互作用分析。
Biochem J. 1988 May 15;252(1):47-54. doi: 10.1042/bj2520047.
3
Purification and functional analysis of human properdin.人备解素的纯化与功能分析
Methods Mol Biol. 2014;1100:161-7. doi: 10.1007/978-1-62703-724-2_13.
4
Properdin binding to complement activating surfaces depends on initial C3b deposition.备解素与补体激活表面的结合取决于初始C3b沉积。
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E534-E539. doi: 10.1073/pnas.1612385114. Epub 2017 Jan 9.
5
Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.备解素独立于C3b与晚期凋亡细胞和坏死细胞结合,并调节替代途径补体激活。
J Immunol. 2008 Jun 1;180(11):7613-21. doi: 10.4049/jimmunol.180.11.7613.
6
The fractionation of human plasma proteins. I. Affinity purification of human complement properdin.人血浆蛋白的分级分离。I. 人补体备解素的亲和纯化。
Protein Expr Purif. 1994 Apr;5(2):164-9. doi: 10.1006/prep.1994.1026.
7
Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement.补体替代途径的正向调节因子——人备解素的分子结构
J Biol Chem. 1984 Apr 10;259(7):4582-8.
8
Association of activated properdin with complexes of properdin with C3.活化备解素与备解素-C3复合物的关联
J Immunol. 1991 Aug 15;147(4):1344-51.
9
Expression and characterisation of the thrombospondin type I repeats of human properdin.人备解素I型血小板反应蛋白重复序列的表达与特性分析
Biochim Biophys Acta. 2001 Aug 13;1548(2):265-77. doi: 10.1016/s0167-4838(01)00238-2.
10
The Role of Properdin in Killing of Non-Pathogenic .补体因子 P 的作用在于杀伤非致病微生物。
Front Immunol. 2020 Nov 10;11:572562. doi: 10.3389/fimmu.2020.572562. eCollection 2020.

引用本文的文献

1
A novel assay that characterizes properdin function shows neutrophil-derived properdin has a distinct oligomeric distribution.一种新型的鉴定备解素功能的检测方法显示,中性粒细胞来源的备解素具有独特的寡聚体分布。
Front Immunol. 2023 Jan 12;13:918856. doi: 10.3389/fimmu.2022.918856. eCollection 2022.
2
Structural studies offer a framework for understanding the role of properdin in the alternative pathway and beyond.结构研究为理解备解素在替代途径中的作用及其以外的作用提供了一个框架。
Immunol Rev. 2023 Jan;313(1):46-59. doi: 10.1111/imr.13129. Epub 2022 Sep 13.
3
Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cells.

本文引用的文献

1
The formation of antibodies against a properdin preparation. II.
Vox Sang. 1960 Feb;5:142-56. doi: 10.1111/j.1423-0410.1960.tb04671.x.
2
The properdin system and immunity. X. Characterization of partially purified human properdin.备解素系统与免疫。X. 部分纯化的人备解素的特性
J Immunol. 1959 Oct;83:428-36.
3
The properdin system and immunity. IX. Studies on the purification of human properdin.备解素系统与免疫。IX. 关于人备解素纯化的研究。
J Immunol. 1959 Oct;83:418-27.
初始备解素结合有助于替代途径在活细胞和坏死细胞表面的激活。
Eur J Immunol. 2022 Apr;52(4):597-608. doi: 10.1002/eji.202149259. Epub 2022 Feb 17.
4
Properdin oligomers adopt rigid extended conformations supporting function.备解素寡聚体采取刚性伸展构象以支持其功能。
Elife. 2021 Jan 22;10:e63356. doi: 10.7554/eLife.63356.
5
Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.补体因子 H 相关蛋白 5 对肾近端小管上皮细胞的影响及其机制研究
Front Immunol. 2020 Aug 7;11:1643. doi: 10.3389/fimmu.2020.01643. eCollection 2020.
6
Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.补体因子 P 的结构及其与 C3b C 末端结构域复合物增强补体激活的研究进展
Front Immunol. 2019 Sep 4;10:2097. doi: 10.3389/fimmu.2019.02097. eCollection 2019.
7
Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications.补体与细菌感染:从分子机制到治疗应用。
J Innate Immun. 2018;10(5-6):455-464. doi: 10.1159/000491439. Epub 2018 Aug 27.
8
The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?补体介导的肾脏疾病中备解素的作用:补体抑制治疗的新靶点?
Pediatr Nephrol. 2019 Aug;34(8):1349-1367. doi: 10.1007/s00467-018-4042-z. Epub 2018 Aug 23.
9
Properdin: A multifaceted molecule involved in inflammation and diseases.备解素:一种参与炎症和疾病的多功能分子。
Mol Immunol. 2018 Oct;102:58-72. doi: 10.1016/j.molimm.2018.05.018. Epub 2018 Jun 27.
10
The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?备解素途径:C3 和 C5 激活的“替代激活途径”还是“关键扩增环”?
Semin Immunopathol. 2018 Jan;40(1):15-35. doi: 10.1007/s00281-017-0661-x. Epub 2017 Nov 22.
4
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.备解素系统与免疫。I. 一种新的血清蛋白——备解素的证实、分离及其在免疫现象中的作用。
Science. 1954 Aug 20;120(3112):279-85. doi: 10.1126/science.120.3112.279.
5
Amino acid sequence studies of human properdin--N-terminal sequence analysis and alignment of the fragments produced by limited proteolysis with trypsin and the peptides produced by cyanogen bromide treatment.人备解素的氨基酸序列研究——N端序列分析以及用胰蛋白酶进行有限蛋白酶解产生的片段与用溴化氰处理产生的肽段的比对
Mol Immunol. 1981 Nov;18(11):949-59. doi: 10.1016/0161-5890(81)90112-7.
6
Properdin is a trimer.备解素是一种三聚体。
Mol Immunol. 1982 Apr;19(4):631-5. doi: 10.1016/0161-5890(82)90232-2.
7
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.系统性红斑狼疮患者红细胞中的补体受体(CR1)缺陷。
J Exp Med. 1982 May 1;155(5):1427-38. doi: 10.1084/jem.155.5.1427.
8
Evidence for presence of an internal thiolester bond in third component of human complement.人补体第三成分中存在内部硫酯键的证据。
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5764-8. doi: 10.1073/pnas.77.10.5764.
9
Native and activated properdin: interconvertibility and identity of amino- and carboxy-terminal sequences.天然和活化的备解素:氨基末端和羧基末端序列的相互转化性及同一性
J Immunol. 1980 Feb;124(2):602-6.
10
Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement.补体替代途径的正向调节因子——人备解素的分子结构
J Biol Chem. 1984 Apr 10;259(7):4582-8.